These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20187504

  • 1. [Infliximab treatment for Behçet's disease--beginning of the biological drug era].
    Namba K.
    Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):85-6. PubMed ID: 20187504
    [No Abstract] [Full Text] [Related]

  • 2. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS, Gavin MP, Sturrock RD.
    Adv Exp Med Biol; 2003 Feb; 528():557-9. PubMed ID: 12918763
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of infliximab on the acute attack of uveitis.
    Alokaily F, Alsaleh S, Al-Balawi M, Al-Rashidi S.
    Saudi Med J; 2010 Jan; 31(1):82-5. PubMed ID: 20062906
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
    Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M.
    Arthritis Res Ther; 2012 May 01; 14(3):R99. PubMed ID: 22546542
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
    Yamada Y, Sugita S, Tanaka H, Kamoi K, Takase H, Mochizuki M.
    Br J Ophthalmol; 2011 Feb 01; 95(2):205-8. PubMed ID: 20542984
    [Abstract] [Full Text] [Related]

  • 14. Behçet disease-associated uveitis successfully treated with golimumab.
    Mesquida M, Victoria Hernández M, Llorenç V, Pelegrín L, Espinosa G, Dick AD, Adán A.
    Ocul Immunol Inflamm; 2013 Apr 01; 21(2):160-2. PubMed ID: 23252659
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].
    Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M.
    Nippon Ganka Gakkai Zasshi; 2010 Feb 01; 114(2):87-95. PubMed ID: 20187505
    [Abstract] [Full Text] [Related]

  • 17. Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.
    Ito T, Sonoda KH, Hijioka K, Fujimoto T, Ishibashi T.
    Jpn J Ophthalmol; 2010 Sep 01; 54(5):502-4. PubMed ID: 21052918
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.